TuHURA Biosciences (HURA) Accumulated Expenses (2023 - 2026)

TuHURA Biosciences' Accumulated Expenses history runs 4 years deep, the most recent figure standing at $1.7 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 17.64% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 17.64% YoY), while the FY2025 annual figure was $1.5 million, up 31.29% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $1.7 million, up from $1.5 million in the prior quarter.
• The five-year high for Accumulated Expenses was $1.7 million in Q1 2026, with the low at $336000.0 in Q3 2024.
• The 4-year median for Accumulated Expenses is $1.2 million (2025), against an average of $1.2 million.
• The sharpest annual moves came in 2024 and 2025: Accumulated Expenses dropped 17.93% in 2024, then soared 261.27% in 2025.
• TuHURA Biosciences' Accumulated Expenses stood at $1.4 million in 2023, then dropped by 17.93% to $1.2 million in 2024, then surged by 31.29% to $1.5 million in 2025, then grew by 12.01% to $1.7 million in 2026.
• Business Quant data shows HURA's Accumulated Expenses at $1.7 million in Q1 2026, $1.5 million in Q4 2025, and $1.2 million in Q3 2025.